Drugs, Diagnostics & Delivery: pharmaceutical discovery through partnership

Location
Birmingham Hippodrome
Category
Medical and Dental Sciences
Date(s)
Wednesday 19th September 2012 (17:30)
Contact

For more information contact Michael Overduin at
Email: michael@sciencecapital.co.uk
Phone: 07810 444 960 or see www.sciencecapital.co.uk

Description
University crest

This inclusive event gives participants the opportunity to discuss the latest developments in the pharmaceutical industry and to build new connections at a time when open innovation, out-sourcing and partnership are increasingly vital.

The evening will include a panel discussion where guests will be able to join in the debate with leading research and business experts following a set of engaging short talks, discuss new developments and present your view.

Speakers include:
Simon Hirst; Founder and Chief Executive Officer of Sygnature Discovery
Sarah Maxfield; Alliance Manager at AstraZeneca Pharmaceuticals
Mike Griffiths; Director of the West Midlands Regional Genetics Laboratory at Birmingham Women's Hospital, and one of the leads on the CRUK Stratified Medicine Programme Technology Hub
Farhat Khanim; Senior Research Fellow at the School of Biosciences, University of Birmingham 
Michael Overduin; Director of the Henry Wellcome Building for Biomolecular NMR Spectroscopy, and is Professor of Structural Biology at the University of Birmingham

The evening will be chaired by Councillor Sir Albert Bore, Leader of Birmingham City Council.

 
There will also be an opportunity to obtain feedback on your business idea and explore new partnerships. Scientists, clinicans, start-ups and SMEs are invited to present their plans for a free private 45 minute consultation during the afternoon with a panel of legal, business, financial and investment advisors.

Places are limited. Please visit healthcare2012.eventbrite.com/ for further details and to register.
Contact Michael Overduin for details, or to submit your 2 page summary.